929 reports of this reaction
3.5% of all BREXPIPRAZOLE reports
#4 most reported adverse reaction
DRUG INEFFECTIVE is the #4 most commonly reported adverse reaction for BREXPIPRAZOLE, manufactured by Otsuka America Pharmaceutical, Inc.. There are 929 FDA adverse event reports linking BREXPIPRAZOLE to DRUG INEFFECTIVE. This represents approximately 3.5% of all 26,345 adverse event reports for this drug.
Patients taking BREXPIPRAZOLE who experience drug ineffective should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DRUG INEFFECTIVE is moderately reported among BREXPIPRAZOLE users, representing a notable but not dominant share of adverse events.
In addition to drug ineffective, the following adverse reactions have been reported for BREXPIPRAZOLE:
The following drugs have also been linked to drug ineffective in FDA adverse event reports:
DRUG INEFFECTIVE has been reported as an adverse event in 929 FDA reports for BREXPIPRAZOLE. This does not prove causation, but indicates an association observed in post-market surveillance data.
DRUG INEFFECTIVE accounts for approximately 3.5% of all adverse event reports for BREXPIPRAZOLE, making it a notable side effect.
If you experience drug ineffective while taking BREXPIPRAZOLE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.